首页> 外文OA文献 >Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

【2h】

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

机译：西利吉肽（一种整合素靶向精氨酸 - 甘氨酸 - 天冬氨酸肽）在复发性多形性胶质母细胞瘤中的随机II期研究

页面导航

著录项
相似文献
相关主题

著录项

作者
David A. Reardon; Karen L. Fink; Tom Mikkelsen; Timothy F. Cloughesy; Scott Plotkin; Michael Glantz; Paula Ravin; Jeffrey J. Raizer; Keith M. Rich; David Schiff; William R. Shapiro; Susan Burdette-radoux; Edward J. Dropcho; Sabine M. Wittemer; Martin Picard; L. Burt Nabors;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. [J] . Reardon DA, Fink KL, Mikkelsen T, Journal of Clinical Oncology . 2008,第34期

机译：西仑吉肽（一种靶向整合素的精氨酸-甘氨酸-天冬氨酸肽）在复发性多形性胶质母细胞瘤中的II期随机研究。
2. Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme. [J] . Reardon DA, Nabors LB, Stupp R, Expert opinion on investigational drugs . 2008,第8期

机译：西仑吉肽：靶向整联蛋白的精氨酸-甘氨酸-天冬氨酸肽，对多形性胶质母细胞瘤具有有希望的活性。
3. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1) [J] . Oliver Oehlke, Michael Mix, Erika Graf, BMC Cancer . 2016,第1期

机译：氨基酸PET和MRI指导的多形性胶质母细胞瘤复发患者（GLIAA）的再次照射–一项II期随机试验的方案（NOA 10 / ARO 2013-1）
4. Implantable peptide-hydrogel drug delivery system for treating glioblastoma multiforme [C] . Arica Gregory, Maggie Elpers, Emilv Miller, Society for Biomaterials annual meeting and exposition . 2019

机译：用于治疗多形性胶质母细胞瘤的可植入肽-水凝胶给药系统
5. I. Studies of cyclic peptides containing the arginine-glycine-aspartic acid pharmacophore. II. Targeting drugs to bone. [D] . Richter, Natali Brooke. 2008

机译：I.含有精氨酸-甘氨酸-天冬氨酸药效团的环状肽的研究。二。将药物靶向骨骼。
6. Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme [O] . David A Reardon, L Burt Nabors, Roger Stupp, -1

机译：Cilengitide：针对整联蛋白的精氨酸-甘氨酸-天冬氨酸肽对多形性胶质母细胞瘤具有有希望的活性
7. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1) [O] . 2016

机译：复发性多形性胶质母细胞瘤（GLIAA）患者中的氨基酸PET与MRI指导下的再照射–一项随机II期试验的方案（NOA 10 / ARO 2013-1）

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

著录项

相似文献

相关主题

期刊订阅